Literature DB >> 17234961

Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha -induced depression of cardiac myocyte contractility.

Anand Kumar1, Bhanu Paladugu, Joel Mensing, Aseem Kumar, Joseph E Parrillo.   

Abstract

Previous studies have demonstrated the presence of myocardial depression in clinical and experimental septic shock. This response is mediated, in part, through circulating TNF-alpha-induced, nitric oxide-dependent, depression of basal myocyte contractility. Other mechanisms of early myocardial dysfunction involving decreased response to adrenergic stimulation may exist. This study evaluated the presence and nitric oxide dependence of impaired adrenergic response to TNF-alpha in in vitro cardiac myocytes. The contraction of electrically paced neonatal rat cardiac myocytes in tissue culture was quantified using a closed-loop video tracking system. TNF-alpha induced depression of baseline contractility over the first 20 min of cardiac myocyte exposure. This effect was blocked by N-methyl-arginine (NMA), a nitric oxide synthase inhibitor, in all studies. Contractile and cAMP response to increasing concentrations of isoproterenol was deficient in cardiac myocytes exposed to TNF-alpha regardless of the presence of NMA. In contrast, increasing concentrations of forskolin (a direct stimulant of adenylate cyclase) and dibutyryl cAMP (a metabolically active membrane-soluble analog of cAMP) completely reversed TNF-alpha-mediated depression, though only in the presence of NMA. Forskolin-stimulated cAMP generation remained intact regardless of NMA. Increasing concentrations of exogenous calcium chloride, unlike other inotropic agents, corrected TNF-alpha-mediated defects of contractility independent of the presence of NMA. These data suggest that TNF-alpha exposure is associated with a second nitric oxide-independent but calcium-dependent early depressant mechanism that is manifested by reduced contractile and cAMP response to beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234961     DOI: 10.1152/ajpregu.00146.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  17 in total

Review 1.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

2.  Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro.

Authors:  Ion A Hobai; Justin C Morse; Deborah A Siwik; Wilson S Colucci
Journal:  J Surg Res       Date:  2014-09-22       Impact factor: 2.192

Review 3.  Cardiorenal [corrected] syndrome: an emerging problem in pediatric critical care.

Authors:  John Lynn Jefferies; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

Review 4.  Cardio-renal syndromes: from foggy bottoms to sunny hills.

Authors:  Claudio Ronco
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 5.  Proinflammatory cytokines in heart failure: double-edged swords.

Authors:  Mona Hedayat; Mohammad Jafar Mahmoudi; Noel R Rose; Nima Rezaei
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

6.  The role of immunostimulatory nucleic acids in septic shock.

Authors:  Farag Bleiblo; Paul Michael; Danielle Brabant; Chilakamarti V Ramana; Tc Tai; Mazen Saleh; Joseph E Parrillo; Anand Kumar; Aseem Kumar
Journal:  Int J Clin Exp Med       Date:  2012-01-15

Review 7.  Fabry's disease: an example of cardiorenal syndrome type 5.

Authors:  Aashish Sharma; Marco Sartori; Jose J Zaragoza; Gianluca Villa; Renhua Lu; Elena Faggiana; Alessandra Brocca; Luca Di Lullo; Sandro Feriozzi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 8.  How are depression and type D personality associated with outcomes in chronic heart failure patients?

Authors:  Jos Widdershoven; Dionne Kessing; Angélique Schiffer; Johan Denollet; Nina Kupper
Journal:  Curr Heart Fail Rep       Date:  2013-09

Review 9.  Tumor necrosis factor-α: regulation of renal function and blood pressure.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

10.  Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.

Authors:  Seyed Soheil Saeedi Saravi; Mahmoud Ghazi-Khansari; Shahram Ejtemaei Mehr; Maliheh Nobakht; Seyyedeh Elaheh Mousavi; Ahmad Reza Dehpour
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.